scholarly article | Q13442814 |
P2093 | author name string | Fox RI | |
Dixon R | |||
Krubel S | |||
Guarrasi V | |||
P921 | main subject | Sjögren's syndrome | Q335555 |
hydroxychloroquine | Q421094 | ||
P304 | page(s) | S31-6 | |
P577 | publication date | 1996-06-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study | |
P478 | volume | 5 Suppl 1 |
Q35176597 | A review on recent advances in dry eye: Pathogenesis and management |
Q37156391 | Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity |
Q36880610 | Bone Mineral Density in Sjögren Syndrome Patients with and Without Distal Renal Tubular Acidosis |
Q36844843 | Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis |
Q41943683 | Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration? |
Q35555698 | Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome |
Q36989837 | Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren's Syndrome: a Double-Blind Randomized Control Study |
Q41936291 | Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome |
Q37827403 | Hydroxychloroquine: from malaria to autoimmunity |
Q33667694 | Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis |
Q35556009 | Lamivudine is not effective in primary Sjögren's syndrome |
Q36131422 | Low-intensity pulsed ultrasound rescues insufficient salivary secretion in autoimmune sialadenitis |
Q64094947 | Managing fatigue in patients with primary Sjögren's syndrome: challenges and solutions |
Q38840388 | New Treatment Guidelines for Sjögren's Disease |
Q48341665 | Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy. |
Q35555323 | Primary Sjögren's syndrome: new clinical and therapeutic concepts |
Q52234497 | Rational drug therapy recommendations for the treatment of patients with Sjögren's syndrome. |
Q90052759 | Recent advances in the search for a targeted immunomodulatory therapy for primary Sjögren's syndrome |
Q30234992 | Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment |
Q26777907 | Salivary Secretory Disorders, Inducing Drugs, and Clinical Management |
Q33777026 | Sialendoscopic management of autoimmune sialadenitis: a review of literature. |
Q39019614 | Sjögren Syndrome and Other Causes of Sicca in Older Adults |
Q87353703 | Sjögren syndrome |
Q37053804 | Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly |
Q38561490 | Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases |
Q44498935 | Topical and systemic medications for the treatment of primary Sjögren's syndrome. |
Q33695804 | Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome |
Q30249011 | Treatment of primary Sjögren syndrome |
Q90003803 | Update on Sjögren Syndrome and Other Causes of Sicca in Older Adults |
Q79145258 | [Sjögren's syndrome. Current aspects from a rheumatological point of view] |
Q87328501 | [Sjögren's syndrome] |
Search more.